Bad Influence? U.K. Questions Pharma’s Sway On Health Care System
This article was originally published in The Tan Sheet
Executive Summary
The U.K. House of Commons Health Committee will hold an "evidence session" Oct. 14 as part of an ongoing inquiry into the pharmaceutical industry's influence on the overall British healthcare system
You may also be interested in...
MHRA Has “Significant Failings” – UK Committee Report
Britain's health authority needs an independent review to determine whether its current decision-making processes adequately reflect patients' health needs, the UK House of Commons Health Committee says
MHRA Has “Significant Failings” – UK Committee Report
Britain's health authority needs an independent review to determine whether its current decision-making processes adequately reflect patients' health needs, the UK House of Commons Health Committee says
MHRA Has “Significant Failings” – UK Committee Report
Britain's health authority needs an independent review to determine whether its current decision-making processes adequately reflect patients' health needs, the UK House of Commons Health Committee says